Secretome Therapeutics
Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy
$30MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Clinical-stage company developing neonatal cardiac progenitor cell therapies for Duchenne-associated cardiomyopathy
Develops inobrodib, a first-in-class oral p300/CBP inhibitor for relapsed or refractory multiple myeloma
Pitching RA Capital Management? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room